Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)
暂无分享,去创建一个
R. Weitkunat | A. Donelli | F. Lüdicke | G. Baker | C. Haziza | D. Skiada | P. Picavet | G. de La Bourdonnaye | V. Poux | Gizelle Baker
[1] P. Wilson,et al. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[2] A. Kondylis,et al. Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes , 2017, Regulatory toxicology and pharmacology : RTP.
[3] D. Postma,et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.
[4] R. Weitkunat,et al. Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2) , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[5] M. Peitsch,et al. Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. , 2016, Regulatory toxicology and pharmacology : RTP.
[6] R. Weitkunat,et al. Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1) , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[7] Rémi H. J. Dulize,et al. In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette. , 2016, Chemical research in toxicology.
[8] G. Assmann,et al. Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). , 1999, Atherosclerosis.
[9] R. Vasan,et al. Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.
[10] Manuel C. Peitsch,et al. An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe−/− Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[11] S. Feng,et al. A 12‐Month, Randomized, Controlled Study to Evaluate Exposure and Cardiovascular Risk Factors in Adult Smokers Switching From Conventional Cigarettes to a Second‐Generation Electrically Heated Cigarette Smoking System , 2008, Journal of clinical pharmacology.
[12] P. Thirumalaikolundusubramanian,et al. Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India , 2010, Tobacco induced diseases.
[13] D. Hatsukami,et al. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US , 2009, Tobacco Control.
[14] P. Lee,et al. The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes , 2013, Biomarker Research.
[15] R. Weitkunat,et al. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[16] M. Peitsch,et al. Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[17] Yuh-Min Song,et al. A short-term smoking cessation may increase the risk of developing metabolic syndrome. , 2015, Diabetes & metabolic syndrome.
[18] B. Palumbo,et al. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). , 2000, Thrombosis research.
[19] Elena Scotti,et al. Comparative systems toxicology analysis of cigarette smoke and aerosol from a candidate modified risk tobacco product in organotypic human gingival epithelial cultures: A 3-day repeated exposure study. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[20] Qi Zhang,et al. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. , 1993, Journal of the American College of Cardiology.
[21] M. Jarvis,et al. The place for harm reduction and product regulation in UK tobacco control policy. , 2008, Journal of public health.
[22] Micah L. Berman,et al. Providing a Science Base for the Evaluation of Tobacco Products. , 2015, Tobacco regulatory science.
[23] P. Pratte,et al. Investigation of solid particles in the mainstream aerosol of the Tobacco Heating System THS2.2 and mainstream smoke of a 3R4F reference cigarette , 2017, Human & experimental toxicology.
[24] Chikako Sakaguchi,et al. Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting. , 2014, Regulatory toxicology and pharmacology : RTP.
[25] S. Feng,et al. Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. , 2008, Regulatory toxicology and pharmacology : RTP.
[26] J. Magnette,et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. , 2012, Regulatory toxicology and pharmacology : RTP.
[27] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[28] R. Wallace,et al. Clearing the Smoke , 2001 .
[29] I. Jang,et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in Korea. , 2012, Regulatory toxicology and pharmacology : RTP.
[30] N. Heidari,et al. How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients? , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[31] R. Wilson,et al. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM‐1, sCD44v5, sCD44v6) , 2002, European journal of clinical investigation.
[32] A Tremblay,et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.
[33] David M. Burns,et al. The scientific basis of tobacco product regulation. , 2007, World Health Organization technical report series.
[34] S. Munjal,et al. Heart Rate Variability Increases With Reductions in Cigarette Smoke Exposure After 3 Days , 2009, Journal of cardiovascular pharmacology and therapeutics.
[35] A. Tricker,et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan. , 2012, Regulatory toxicology and pharmacology : RTP.
[36] M. Peitsch,et al. Aerosol from Tobacco Heating System 2.2 has reduced impact on mouse heart gene expression compared with cigarette smoke. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[37] Ashraf Elamin,et al. A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[38] D. Lúdvíksdóttir,et al. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation , 1999, Journal of internal medicine.
[39] H. Rodríguez-Hernández,et al. Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation , 2013, International journal of endocrinology.
[40] B. Palumbo,et al. Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults. , 2000, VASA. Zeitschrift fur Gefasskrankheiten.
[41] M. Unverdorben,et al. Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. , 2010, Regulatory toxicology and pharmacology : RTP.
[42] S. Feng,et al. Short‐Term Clinical Exposure Evaluation of a Second‐Generation Electrically Heated Cigarette Smoking System , 2007, Journal of clinical pharmacology.
[43] S. Munjal,et al. Effects of Different Levels of Cigarette Smoke Exposure on Prognostic Heart Rate and Rate—Pressure-Product Parameters , 2008, Journal of cardiovascular pharmacology and therapeutics.
[44] Ashraf Elamin,et al. A systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[45] C. Leroy,et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan. , 2012, Regulatory toxicology and pharmacology : RTP.
[46] J. Morrow,et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.
[47] Megan E. Piper,et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.
[48] P. Vanscheeuwijck,et al. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. , 2016, Regulatory toxicology and pharmacology : RTP.
[49] A. Luch,et al. Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks , 2018, Archives of Toxicology.
[50] S. Tonstad,et al. C-reactive protein as a predictor of disease in smokers and former smokers: a review , 2009, International journal of clinical practice.
[51] K. Farsalinos,et al. Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e‐cigarette and a tobacco cigarette , 2018, Addiction.
[52] Acute effects of cigarette smoking on pulmonary function. , 2010, Regulatory toxicology and pharmacology : RTP.
[53] H. Sinzinger,et al. Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. , 1999, Wiener klinische Wochenschrift.
[54] Manuel C. Peitsch,et al. Comprehensive systems biology analysis of a 7-month cigarette smoke inhalation study in C57BL/6 mice , 2016, Scientific Data.
[55] S. Feng,et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[56] R. Weitkunat,et al. Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1) , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[57] M C Peitsch,et al. Systems toxicology meta-analysis of in vitro assessment studies: biological impact of a candidate modified-risk tobacco product aerosol compared with cigarette smoke on human organotypic cultures of the aerodigestive tract† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7tx , 2017, Toxicology research.
[58] S. Feng,et al. 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. , 2008, Regulatory toxicology and pharmacology : RTP.
[59] Q. Liang,et al. Effects of levels of cigarette smoke exposure on symptom-limited spiroergometry. , 2007, Preventive cardiology.
[60] M Feinleib,et al. Obesity and lipoprotein cholesterol in the Framingham offspring study. , 1980, Metabolism: clinical and experimental.
[61] Å. Westin,et al. Effect of smoking reduction and cessation on cardiovascular risk factors. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[62] R. Kinser,et al. Short‐Term Exposure Evaluation of Adult Smokers Switching From Conventional to First‐Generation Electrically Heated Cigarettes During Controlled Smoking , 2005, Journal of clinical pharmacology.
[63] G. Scherer. Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review. , 2018, Regulatory toxicology and pharmacology : RTP.
[64] Megan E. Piper,et al. Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk , 2017, Arteriosclerosis, thrombosis, and vascular biology.